Literature DB >> 4268472

Distribution of 3 H-labelled 6-aminonicotinamide and accumulation of 6-phosphogluconate in the spinal cord.

G Meyer-Estorf, P E Schulze, H Herken.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4268472     DOI： 10.1007/bf00501195

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  9 in total

1.  Mechanism of action of transaldolase. I. Crystalization and properties of yeast enzyme.

Authors:  R VENKATARAMAN; E RACKER
Journal:  J Biol Chem       Date:  1961-07       Impact factor: 5.157

2.  The effects of an antimetabolite, 6-amino-nicotinamide, on the central nervous system.

Authors:  A WOLF; D COWEN; L M GELLER
Journal:  Trans Am Neurol Assoc       Date:  1959

3.  6-Aminonicotinamide and acute degenerative changes in the central nervous system.

Authors:  S S STERNBERG; F S PHILIPS
Journal:  Science       Date:  1958-03-21       Impact factor: 47.728

4.  [Morphological findings in the central nervous system of the rat after poisoning with antimetabolites of nicotinamide (6-aminonicotinamide and 3-acetylpyridine) and a quinoline derivative (5-nitro-8-hydroxyquinoline)].

Authors:  H Schneider; H Coper
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1968-08-22

5.  Blocking of pentose phosphate pathway in the brain of rats by 6-aminonicotinamide.

Authors:  H Herken; K Lange
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1969

6.  [Studies on the mechanism of functional disturbances of the central nervous system by 6-aminonicotinamide].

Authors:  H Coper; H Hadass; H Lison
Journal:  Naunyn Schmiedebergs Arch Pharmakol Exp Pathol       Date:  1966

7.  Brain disorders induced by pharmacological blockade of the pentose phosphate pathway.

Authors:  H Herken; K Lange; H Kolbe
Journal:  Biochem Biophys Res Commun       Date:  1969-07-07       Impact factor: 3.575

8.  Behaviour of the glycolytic system of rat brain and kidney in vivo after in hibition of the glucosephosphate isomerase. II. Substrate concentrations under the influence of ischemia, 6-aminonicotinamide, and 2-deoxyglucose.

Authors:  K Keller; H Kolbe; K Lange; H Herken
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1972-09

9.  [Brain carbohydrate metabolism following blockade of the pentose phosphate pathway by 6-aminonicotinamide].

Authors:  K Lange; H Kolbe; K Keller; H Herken
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1970-10
  9 in total
  3 in total

1.  [Experimental myelopathy--biochemical basis of its cellular pathogenesis (author's transl)].

Authors:  H Herken; K Keller; H Kolbe; K Lange; H Schneider
Journal:  Klin Wochenschr       Date:  1973-07-01

2.  Identification of an intracellular metabolic signature impairing beta cell function in the rat beta cell line INS-1E and human islets.

Authors:  I Goehring; N S Sauter; G Catchpole; A Assmann; L Shu; K S Zien; M Moehlig; A F H Pfeiffer; J Oberholzer; L Willmitzer; J Spranger; K Maedler
Journal:  Diabetologia       Date:  2011-07-28       Impact factor: 10.122

3.  Spastic paresis after 6-aminonicotinamide: metabolic disorders in the spinal cord and electromyographically recorded changes in the hind limbs of rats.

Authors:  H Herken; G Meyer-Estorf; K Halbhübner; D Loos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-06       Impact factor: 3.000
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.